IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer

Background: A combination therapy with immune checkpoint inhibitors (ICIs) and platinum-based chemotherapy has become the first-line treatment for recurrent or metastatic head and neck squamous carcinoma (HNSCC). Although steroids are often used as anti-emetic medications during chemotherapy, their...

Descripción completa

Detalles Bibliográficos
Autores principales: Kono, Michihisa, Yamaki, Hidekiyo, Komatsuda, Hiroki, Kumai, Takumi, Hayashi, Ryusuke, Wakisaka, Risa, Sato, Ryosuke, Ohara, Kenzo, Kishibe, Kan, Takahara, Miki, Katada, Akihiro, Hayashi, Tatsuya, Harabuchi, Yasuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819385/
https://www.ncbi.nlm.nih.gov/pubmed/35123188
http://dx.doi.org/10.1016/j.tranon.2022.101358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819385/
https://www.ncbi.nlm.nih.gov/pubmed/35123188
http://dx.doi.org/10.1016/j.tranon.2022.101358

Ejemplares similares